Hologic Inc (STU:HO1)
€ 72 -4.5 (-5.88%) Market Cap: 16.83 Bil Enterprise Value: 17.02 Bil PE Ratio: 23.66 PB Ratio: 3.57 GF Score: 87/100

Hologic Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 14, 2020 / 08:30PM GMT
Release Date Price: €52 (-0.95%)
David Ryan Lewis
Morgan Stanley, Research Division - MD

Well, good afternoon, everyone, and thanks for joining us here as we progress through the afternoon of the Morgan Stanley 2020 Healthcare Conference. It's a pleasure to have with us here, Hologic, which has obviously been a company that's been critical to the defense against COVID-19, and we're pleased to have multiple members of management both Steve MacMillan, CEO; Karleen Oberton, the CFO; and Mike Watts, VP of IR Communications. Steve is going to give us a quick 45-second preamble and we're going to -- then we're going to get into it. As I've said all day, please check out my research disclosures on the Morgan Stanley website, morganstanley.com/researchdisclosures.

With that, Steve, I'll turn it over to you before jumping into Q&A.

Stephen P. MacMillan
Hologic, Inc. - Chairman, CEO & President

Great. Thanks, David. Great to see you. And I'll be real quick here. I think the way we think about where the company sits today is, obviously, we're so proud of the way our team has responded

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot